- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01821807
Comparison of Two Spinal Needles Regarding Postdural Puncture Headache
Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section, Two Different Needles.
The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients.
Two kind of spinal anesthesia needles will be used:
- 26 Gauge Quincke (cutting-tip needle)
- 26 Gauge Atraucan (atraumatic needle)
The investigators will observe:
- Number of spinal punctures
- Time required for the spinal anesthesia procedure
Patients will be evaluated after 7 days for:
- Headache
- Backache
Studieoversikt
Status
Detaljert beskrivelse
It is a known phenomenon that spinal anesthesia sometimes results in headache.
The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients.
Two kind of spinal anesthesia needles will be used:
- 26 Gauge Quincke (cutting-tip needle)
- 26 Gauge Atraucan (atraumatic needle)
We will observe:
- Number of spinal punctures
- Time required for the spinal anesthesia procedure
Patients will be evaluated after 7 days for:
- Headache
- Backache
2 kind of spinal anesthesia needles will be used, but no comparison will be made. This is an observational study. Although literature gives different rates of postdural puncture headache for these two needles, we observe the same rate of headache in our clinical practice. We want to define the real rate of postdural puncture headache in patients undergoing cesarean section with spinal anesthesia.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Adiyaman, Tyrkia
- Adiyaman University Research Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Pregnant female patients between 18-40 years old undergoing cesarean section
- Patient accepting spinal anesthesia
Exclusion Criteria:
- Infection at the spinal needle insertion cite
- Coagulability disorder
- Patient not accepting the procedure
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
26 gauge quincke
Patients (n=150) will be treated with 26 gauge quincke spinal needle for spinal anesthesia for cesarean section.
|
26 gauge atraucan
Patients (n=110) will be treated with 26 gauge atraucan spinal needle for spinal anesthesia for cesarean section.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Postdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section
Tidsramme: 1 week
|
Patients were observer for the symptoms of headache (PDPH) for 1 week.
On the 1st postoperative day they were visited in the clinic.
On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.
|
1 week
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Backache in Patients Receiving Spinal Anesthesia for Cesarean Section
Tidsramme: 1 week
|
Patients were observer for the symptoms of postdural puncture backache for 1 week.
On the 1st postoperative day they were visited in the clinic.
On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.
|
1 week
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Ruslan Abdullayev, Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- PDPH 26Q26A
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .